What does reportable segment — gain on sale of business mean?

This metric records the profit realized from the divestiture or sale of a business unit or significant asset group within the reportable segment. It is a non-recurring item that provides a one-time boost to the segment's financial results. Investors monitor this to distinguish between gains from core operational growth and gains from capital allocation or portfolio optimization activities.

Twist Bioscience Corporation TWST Reportable Segment — Gain on sale of business

Similar metrics at other companies

GXOReportable Segment — Gain (Loss) on Disposition of Business

-$21M—

LUMNReportable Segment — Gain (Loss) on Disposition of Business

$596M—

LAMRReportable Segment — Gain on disposition of assets and investments

$12.6M-81.9%

BAXReportable Segment — Gain (Loss) on Disposition of Assets

-$4M—

CPTReportable Segment — Gain on sale of operating property, including land

$68.1M—

ACIReportable Segment — Gain (loss) on property dispositions and impairment losses, net

$1.2M+112%

Other financials

Income statement

See full

Revenue$110.7M+19.3%

Gross profit$57.1M+24.1%

Operating income-$45.9M-10.4%

Net income-$44.0M-11.9%

EPS (diluted)-$0.71-7.6%

Balance sheet

See full

Cash & equivalents$124.9M-41.4%

Total debt$110.8M+16.3%

Total equity$455.1M+3.4%

Total assets$676.2M+13.5%

Cash flow

See full

Operating cash flow-$17.6M-35.2%

CapEx$7.9M+90.3%

Free cash flow-$25.4M-48.5%

Valuation

See full

Market cap$5.45B+24.4%

Profitability

See full

Gross margin52.1%+5.4pp

Operating margin-33.9%-9.9pp

Net margin-19.8%-7.7pp

FCF margin-23.2%+7.0pp

Returns & leverage

See full

Return on equity-18.2%-6.3pp

Debt / equity0.2×0.0×

Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: Twist Bioscience Corporation’s 10-K, filed November 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's reportable segment — gain on sale of business.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Twist Bioscience Corporation's reportable segment — gain on sale of business?: Twist Bioscience Corporation (TWST) reported reportable segment — gain on sale of business of $12.21M in Q3 2025.
What does reportable segment — gain on sale of business mean?: This metric records the profit realized from the divestiture or sale of a business unit or significant asset group within the reportable segment. It is a non-recurring item that provides a one-time boost to the segment's financial results. Investors monitor this to distinguish between gains from core operational growth and gains from capital allocation or portfolio optimization activities.